文献速递胃肠外科围术期管理与 ERAS

结直肠手术中的液体管理与升压药使用:寻找最佳平衡

Fluid management and vasopressor use during colorectal surgery: the search for the optimal balance.
PubMed 文献 · Surg Endosc · 2023-05-01

该研究为LekCheck前瞻性观察性研究的二次分析,纳入1548例接受结直肠切除并一期吻合的成人患者。术中37%使用了升压药,使用升压药者吻合口漏发生率为11.8% vs 未使用者的6.3%(p<0.001),多因素分析显示术中升压药与吻合口漏风险增加独立相关(OR 2.1,CI 1.3-3.2,p=0.001)。

要点

  • 术中升压药使用与结直肠吻合口漏风险增加相关(OR 2.1)。
  • 去氧肾上腺素组吻合口漏率高于去甲肾上腺素组(14.3% vs 6%)。
  • 使用升压药者30天死亡率更高(2.8% vs 0.4%,OR 3.8)。

核心结论

  • 术中升压药使用与结直肠吻合口漏发生率升高相关,需关注升压药使用的必要性及剂量平衡。

研究设计与样本

  • LekCheck前瞻性观察性研究的二次分析,纳入1548例接受结直肠切除并一期吻合的成人患者。

主要发现

  • 579例(37%)术中使用了升压药,其中201例仅用去甲肾上腺素,349例用去氧肾上腺素,29例用麻黄碱。
  • 使用升压药者吻合口漏发生率为11.8%,未使用者为6.3%(p<0.001)。
  • 去氧肾上腺素组吻合口漏率为14.3%,高于去甲肾上腺素组的6%(p<0.001)。
  • 使用升压药者30天死亡率为2.8%,未使用者为0.4%(p=0.01,OR 3.8)。
  • 多因素分析显示术中升压药与吻合口漏风险增加相关(OR 2.1,CI 1.3-3.2,p=0.001)。

临床怎么用

  • 结直肠手术中应审慎使用升压药,权衡吻合口愈合风险,避免不必要的升压药暴露。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although it is known that excessive intraoperative fluid and vasopressor agents are detrimental for anastomotic healing, optimal anesthesiology protocols for colorectal surgery are currently lacking. OBJECTIVE: To scrutinize the current hemodynamic practice and vasopressor use and their relation to colorectal anastomotic leakage. DESIGN: A secondary analysis of a previously published prospective observational study: the LekCheck study. STUDY SETTING: Adult patients undergoing a colorectal resection with the creation of a primary anastomosis. OUTCOME MEASURES: Colorectal anastomotic leakage (CAL) within 30 days postoperatively, hospital length of stay and 30-day mortality. RESULTS: Of the 1548 patients, 579 (37%) received vasopressor agents during surgery. Of these, 201 were treated with solely noradrenaline, 349 were treated with phenylephrine, and 29 received ephedrine. CAL rate significantly differed between the patients receiving vasopressor agents during surgery compared to patients without (11.8% vs 6.3%, p < 0.001). CAL was significantly higher in the group receiving phenylephrine compared to noradrenaline (14.3% vs 6%, p < 0.001). Vasopressor agents were used more often in patients treated with Goal Directed Therapy (47% vs 34.6%, p < 0.001). There was a higher mortality rate in patients with vasopressors compared to the group without (2.8% vs 0.4%, p = 0.01, OR 3.8). Mortality was higher in the noradrenaline group compared to the phenylephrine and those without vasopressors (5% vs. 0.4% and 1.7%, respectively, p < 0.001). In multivariable analysis, patients with intraoperative vasopressor agents had an increased risk to develop CAL (OR 2.1, CI 1.3-3.2, p = 0.001). CONCLUSION: The present study contributes to the evidence that intraoperative use of vasopressor agents is associated with a higher rate of CAL. This study helps to create awareness on the (necessity to) use of vasopressor agents in colorectal surgery patients in striving for successful anastomotic wound healing. Future research will be required to balance vasopressor agent dosage in view of colorectal anastomotic leakage.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Huisman DE, Bootsma BT, Ingwersen EW, et al. Fluid management and vasopressor use during colorectal surgery: the search for the optimal balance. Surg Endosc. 2023. PMID: 37126191. doi:10.1007/s00464-023-09980-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。